1
Home
Companies

Milestone Pharmaceuticals

#9269

Rank

$70.96M

Marketcap

CA Canada

Country

Milestone Pharmaceuticals
Leadership team

Mr. Joseph G. Oliveto M.B.A. (CEO, Pres & Director)

Mr. Amit Hasija (CFO & Exec. VP of Corp. Devel.)

Dr. Philippe Douville M.B.A., Ph.D. (Founder, Strategic Advisor & Member of Scientific Advisory Board)

Products/ Services
Biotechnology, Health Care, Therapeutics
Headquarters
Montréal, Quebec, Canada
Established
2005
Company Registration
SEC CIK number: 0001408443
Revenue
500K - 2M
Traded as
MIST
Social Media
URL
https://www.milestonepharma.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.
History

Milestone Pharmaceuticals was founded in 2011 by experienced cardiovascular drug development veterans, focused on the development of novel and effective treatments for cardiovascular diseases and disorders. They have secured a total of over $80M in venture capital funding, while attracting experienced pharmaceutical industry professionals and expanding their partnerships in the pharmaceutical, educational and corporate sectors.

Mission
Our mission is to create safe and effective cardiovascular therapeutics that address unmet patient needs.
Vision
Our vision is to provide innovative and safe treatments to patients suffering from cardiovascular diseases and disorders.
Key Team

Mr. Jeff Nelson (Chief Operating Officer)

Mr. Roshan Girglani (VP of Marketing)

Ms. Kimberly Sheehan (VP of HR)

Dr. Guy Rousseau (SVP of Regulatory Affairs and Quality Management)

Mr. Lorenz Muller (Chief Commercial Officer)

Dr. Philip T. Sager FACC, FAHA, FHRS, M.D. (Chief Medical Advisor & Member of the Scientific Advisory Board)

Dr. David B. Bharucha FACC, M.D., Ph.D. (Chief Medical Officer)

Recognition and Awards
Milestone has been recognized in 2020 by the CEO Today Awards as the Best Biotech Startup and has been selected in 2021 for the Healthtech awards for the Best Digital Health Platform.
References

https://in.investing.com/equities/milestone-pharmaceuticals-inc

https://finance.yahoo.com/quote/MIST/profile?p=MIST

https://www.crunchbase.com/organization/milestone-pharmaceuticals

https://companiesmarketcap.com/

https://www.milestonepharma.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Milestone Pharmaceuticals
Leadership team

Mr. Joseph G. Oliveto M.B.A. (CEO, Pres & Director)

Mr. Amit Hasija (CFO & Exec. VP of Corp. Devel.)

Dr. Philippe Douville M.B.A., Ph.D. (Founder, Strategic Advisor & Member of Scientific Advisory Board)

Products/ Services
Biotechnology, Health Care, Therapeutics
Headquarters
Montréal, Quebec, Canada
Established
2005
Company Registration
SEC CIK number: 0001408443
Revenue
500K - 2M
Traded as
MIST
Social Media
URL
https://www.milestonepharma.com